← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Imquest Biosciences
Frederick, MD
$29,253,621
Total funding
30
Grants
Funding over time
peak $9M · FY2005–16$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$29,253,621 · 30
By mechanism
U19$21,495,379 · 16
R44$2,587,844 · 2
R33$2,539,874 · 2
R21$1,584,274 · 5
R43$1,046,250 · 5
Investigators at Imquest Biosciences
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development and Evaluation of Dual Compartment Combination Microbicides$3,574,067
U19 · FY2013 · AI
Development and Evaluation of Dual Compartment Combination Microbicides$3,224,012
U19 · FY2012 · AI
Development and Evaluation of Dual Compartment Combination Microbicides$2,876,353
U19 · FY2014 · AI
Development and Evaluation of Dual Compartment Combination Microbicides$2,443,193
U19 · FY2015 · AI
Development and Evaluation of Dual Compartment Combination Microbicides$2,149,121
U19 · FY2016 · AI
Long Acting Acceptable Microbicides: Novel Delivery, Activity and Pharmacodynamic$1,578,326
U19 · FY2010 · AI
Long Acting Acceptable Microbicides: Novel Delivery, Activity and Pharmacodynamic$1,389,746
U19 · FY2009 · AI
Long Acting Acceptable Microbicides: Novel Delivery, Activity and Pharmacodynamic$1,374,317
U19 · FY2008 · AI
Long Acting Acceptable Microbicides: Novel Delivery, Activity and Pharmacodynamic$1,265,859
U19 · FY2011 · AI
Long Acting Acceptable Microbicides: Novel Delivery, Activity and Pharmacodynamic$1,080,708
U19 · FY2012 · AI
Pre-Phase I Evaluations$982,834
U19 · FY2013 · AI
Critical Path IND-enabling Studies, Regulatory, and Product Development$942,042
U19 · FY2012 · AI
Critical Path IND-enabling Studies, Regulatory, and Product Development$939,369
U19 · FY2013 · AI
Mechanism of Action of Novel Dual Acting Pyrimidinediones$919,455
R44 · FY2010 · AI
Mechanism of Action of Novel Dual Acting Pyrimidinediones$861,701
R44 · FY2011 · AI
Pre-Phase I Evaluations$742,671
U19 · FY2016 · AI
Pre-Phase I Evaluations$737,182
U19 · FY2014 · AI
Evaluating User Perceptions and Experience of Dual Compartment Microbicide Form.$709,565
U19 · FY2013 · AI
Pre-Phase I Evaluations$671,733
U19 · FY2015 · AI
Pre-Phase I Evaluations$575,586
U19 · FY2012 · AI